| Name | Title | Contact Details |
|---|---|---|
Alexandria Haigh |
Director, Strategic Marketing | Profile |
Shane Kraft |
Associate Director of Finance | Profile |
Andrea Simmons |
Associate Director of HR Technology | Profile |
John Futrelle |
Director, Finance - Vaccine Sciences | Profile |
Cara Koch |
Director, Strategic Finance | Profile |
UNITY Biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY`s initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases.
Innovative Spinal Technologies is a Mansfield, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Genyous Life Sciences is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Cullgen is a privately held biopharmaceutical company dedicated to the development of first-in-class new chemical entities (NCEs) for the treatment of diseases lacking effective therapeutic approaches.
Artiva Biotherapeutics is a private biotech company advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, for the treatment of hematologic cancers or solid tumors. Artiva Biotherapeutics was founded on the understanding that NK cells hold enormous therapeutic potential as cancer therapies and the dedication and expertise to overcome technological barriers in the scaling and manufacturing of these cells. At Artiva, our mission is to deliver highly effective cell therapies that are also safe and immediately available and accessible to any cancer patient who stands to benefit. Artiva`s platform delivers scalability, quality, and cryopreservation to support a pipeline of safe, effective, versatile, and accessible product candidates.